Clinical Edge Journal Scan

A healthy lifestyle may prevent the development of RA


 

Key clinical point: A healthy lifestyle was associated with a reduced risk of developing rheumatoid arthritis (RA) overall, as well as for seropositive and seronegative RA.

Major finding: Each unit increase in healthy lifestyle index score was associated with a reduced risk for overall RA (hazard ratio [HR] 0.86; P < .0001), seropositive RA (HR 0.85; P < .0001), and seronegative RA (HR 0.87; P < .001).

Study details: The findings come from an analysis of 2 large prospective cohorts including 107,092 women, among which 1,219 cases of incident RA (seropositive, 776; seronegative, 443) were identified.

Disclosures: The study was supported by the National Institutes of Health and Rheumatology Research Foundation Career Development Bridge Award. The authors declared no conflicts of interest.

Source: Hahn J et al. Arthritis Care Res (Hoboken). 2022 (Jan 18). Doi: 10.1002/acr.24862

Recommended Reading

Lilly calls it quits on baricitinib’s development for lupus
MDedge Rheumatology
Boxed warning for JAK inhibitors belies their durability in real-world registry studies
MDedge Rheumatology
Dietary recommendations for inflammatory rheumatic diseases
MDedge Rheumatology
Patients are interrupting DMARD use well into the COVID-19 pandemic
MDedge Rheumatology
Treat-to-target in RA: Questions remain about adoption, measurement
MDedge Rheumatology
Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitors
MDedge Rheumatology
More evidence supporting ultra-low retreatment dose of rituximab in RA
MDedge Rheumatology
Acute exacerbation affects prognosis in RA-associated interstitial lung disease
MDedge Rheumatology
A real-world analysis finds no evidence of increased CV risk with tofacitinib vs. TNFi in RA
MDedge Rheumatology
Early RA: Prevalence and factors associated with methotrexate-related adverse events
MDedge Rheumatology